Bonfa E - Search Results

1

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal.

Pons-Estel BA, Sánchez-Guerrero J, Romero-Díaz J, Iglesias-Gamarra A, Bonfa E, Borba EF, Shinjo SK, Bernatsky S, Clarke A, García MA, Marcos JC, Duarte A, Berbotto GA, Scherbarth H, Marques CD, Onetti L, Saurit V, Souza AW, Velozo E, Catoggio LJ, Neira O, Burgos PI, Ramirez LA, Molina JF, De La Torre IG, Silvariño R, Manni JA, Durán-Barragán S, Vilá LM, Fortin PR, Calvo-Alén J, Santos MJ, Portela M, Esteva-Spinetti MH, Weisman M, Acevedo EM, Segami MI, Gentiletti SB, Roldán J, Navarro I, Gonzalez E, Liu JM, Karlson EW, Costenbader KH, Wolfe F, Alarcón GS. Pons-Estel BA, et al. Among authors: bonfa e. Lupus. 2009 Oct;18(12):1033-52. doi: 10.1177/0961203309105590. Lupus. 2009. PMID: 19762375 Free PMC article.

2

Lipoprotein(a) levels in systemic lupus erythematosus.

Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhão RC. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 1994 Feb;21(2):220-3. J Rheumatol. 1994. PMID: 8182628

3

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 1997;6(6):533-9. doi: 10.1177/096120339700600610. Lupus. 1997. PMID: 9256312

4

Chylomicron metabolism is markedly altered in systemic lupus erythematosus.

Borba EF, Bonfá E, Vinagre CG, Ramires JA, Maranhão RC. Borba EF, et al. Among authors: bonfa e. Arthritis Rheum. 2000 May;43(5):1033-40. doi: 10.1002/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B. Arthritis Rheum. 2000. PMID: 10817556 Free article.

5

Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 2001 Apr;28(4):780-5. J Rheumatol. 2001. PMID: 11327250

6

Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.

Borba EF, Turrini-Filho JR, Kuruma KA, Bertola C, Pedalini ME, Lorenzi MC, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 2004;13(4):223-7. doi: 10.1191/0961203304lu528oa. Lupus. 2004. PMID: 15176656

7

The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus.

Hayata AL, Borba EF, Bonfá E, Kochen JA, Goldenstein-Schainberg C. Hayata AL, et al. Among authors: bonfa e. Lupus. 2005;14(8):613-7. doi: 10.1191/0961203305lu2177oa. Lupus. 2005. PMID: 16175933

8

Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis.

Shinzato MM, Bueno C, Trindade Viana VS, Borba EF, Gonçalves CR, Bonfá E. Shinzato MM, et al. Among authors: bonfa e. Lupus. 2005;14(12):953-8. doi: 10.1191/0961203305lu2252oa. Lupus. 2005. PMID: 16425575

9

Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.

Fialho SC, Bonfá E, Vitule LF, D'Amico E, Caparbo V, Gualandro S, Pereira RM. Fialho SC, et al. Among authors: bonfa e. Lupus. 2007;16(4):239-44. doi: 10.1177/0961203307076771. Lupus. 2007. PMID: 17439929

10

Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.

Sachet JC, Borba EF, Bonfá E, Vinagre CG, Silva VM, Maranhão RC. Sachet JC, et al. Among authors: bonfa e. Lupus. 2007;16(4):273-8. doi: 10.1177/09612033070160040901. Lupus. 2007. PMID: 17439934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters